loadpatents
Patent applications and USPTO patent grants for Poznansky; Mark.The latest application filed is for "use of cxcl12 to promote survival, function, and immunoisolation of stem cell-derived beta cells".
Patent | Date |
---|---|
Use Of Cxcl12 To Promote Survival, Function, And Immunoisolation Of Stem Cell-derived Beta Cells App 20200323784 - Poznansky; Mark ;   et al. | 2020-10-15 |
Eluting matrix and uses thereof Grant 9,849,094 - Poznansky , et al. December 26, 2 | 2017-12-26 |
Methods For Preventing Fibrosis Using Cxcr4 And/or Cxcr7 Binding Agents App 20170304400 - Poznansky; Mark ;   et al. | 2017-10-26 |
Eluting Matrix and Uses Thereof App 20160354321 - POZNANSKY; Mark ;   et al. | 2016-12-08 |
Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof Grant 5,981,276 - Sodroski , et al. November 9, 1 | 1999-11-09 |
Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof Grant 5,665,577 - Sodroski , et al. September 9, 1 | 1997-09-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.